Insmed reported $142.38M in Stock for its fiscal quarter ending in June of 2026.





Stock Change Date
BioMarin Pharmaceutical USD 1.78B 509.3M Jun/2026
Cytokinetics USD 380K 226K Jun/2026
Gilead Sciences USD 1.91B 140M Mar/2026
Heron Therapeutics USD 54.57M 2.33M Dec/2022
Insmed USD 142.38M 9.48M Jun/2026
Novartis USD 6.29B 135M Mar/2026
Regeneron Pharmaceuticals USD 3.08B 19.3M Jun/2026
Sarepta Therapeutics USD 904.27M 96.84M Jun/2026
Ultragenyx Pharmaceutical USD 59M 4M Jun/2026
Vertex Pharmaceuticals USD 1.77B 1.6M Jun/2026